[go: up one dir, main page]

AR105701A1 - METHODS AND CASES TO TREAT DEPRESSION - Google Patents

METHODS AND CASES TO TREAT DEPRESSION

Info

Publication number
AR105701A1
AR105701A1 ARP160102492A ARP160102492A AR105701A1 AR 105701 A1 AR105701 A1 AR 105701A1 AR P160102492 A ARP160102492 A AR P160102492A AR P160102492 A ARP160102492 A AR P160102492A AR 105701 A1 AR105701 A1 AR 105701A1
Authority
AR
Argentina
Prior art keywords
methods
cases
treatment
depression
treat depression
Prior art date
Application number
ARP160102492A
Other languages
Spanish (es)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Priority to ARP160102492A priority Critical patent/AR105701A1/en
Publication of AR105701A1 publication Critical patent/AR105701A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Métodos y estuches para el tratamiento de la depresión (preferiblemente, depresión resistente al tratamiento), o para el tratamiento de la depresión en un paciente suicida y/o para el tratamiento y/o prevención de suicidios (p. ej., pensamientos suicidas) que incluyen la administración de esketamina de acuerdo con ciertos regímenes de dosis.Methods and kits for the treatment of depression (preferably, treatment-resistant depression), or for the treatment of depression in a suicidal patient and / or for the treatment and / or prevention of suicides (e.g., suicidal thoughts) which include the administration of esketamine according to certain dose regimens.

ARP160102492A 2016-08-12 2016-08-12 METHODS AND CASES TO TREAT DEPRESSION AR105701A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ARP160102492A AR105701A1 (en) 2016-08-12 2016-08-12 METHODS AND CASES TO TREAT DEPRESSION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP160102492A AR105701A1 (en) 2016-08-12 2016-08-12 METHODS AND CASES TO TREAT DEPRESSION

Publications (1)

Publication Number Publication Date
AR105701A1 true AR105701A1 (en) 2017-11-01

Family

ID=60451235

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160102492A AR105701A1 (en) 2016-08-12 2016-08-12 METHODS AND CASES TO TREAT DEPRESSION

Country Status (1)

Country Link
AR (1) AR105701A1 (en)

Similar Documents

Publication Publication Date Title
DOP2017000268A (en) METHODS AND KITS TO TREAT DEPRESSION
DOP2017000271A (en) PATIENT CONDITIONING METHODS FOR T-LYMPHOCYT TREATMENT
CL2018001152A1 (en) Compositions and methods for cancer treatment
CR20190350A (en) ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFß1 INHIBITORS AND USE THEREOF
MX2018008514A (en) COMPOSITIONS AND METHODS RELATED TO MULTIMODAL THERAPEUTIC CELL SYSTEMS FOR CANCEROSE INDICATIONS.
MX388325B (en) DIAGNOSTIC METHODS FOR T LYMPHOCYTE TREATMENT.
BR112018003985A2 (en) peptidomimetic macrocycles and their uses
MX2022008868A (en) Treatment of cancer with tg02.
BR112018008882A2 (en) method for treating a proliferative disorder and pharmaceutical
MX2018006674A (en) CANCER TREATMENT USING 2-DESOXI-2-FLUORO-L-FUCOSA IN COMBINATION WITH A CONTROL POINT INHIBITOR.
AR101312A1 (en) COMBINATIONS OF BET INHIBITORS AND INHIBITORS OF TIROSINA QUINASA DE BRUTON
CL2017003152A1 (en) Hydroxypropyl beta-cyclodextrin compositions and methods
CR20170259A (en) POISON THERAPIES AND PHARMACEUTICAL COMPOSITIONS, SYSTEMS AND RELATED EQUIPMENT
MX374749B (en) COMBINATION THERAPY INCLUDING A TOR KINASE INHIBITOR AND A CYTIDINE ANALOGUE TO TREAT CANCER.
BR112019003533A2 (en) combination therapy with glutaminase inhibitors
DOP2018000034A (en) COMBINATIONS OF AN OX40 ANTIBODY AND A TLR4 MODULATOR AND USES OF THE SAME
MX2017009122A (en) DRY POWDER INHALER WITH FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE.
AR104598A1 (en) METHODS FOR TREATMENT LINFOPROLIFERATIVE DISORDERS ASSOCIATED WITH THE EPSTEIN-BARR VIRUS THERAPY WITH T-CELLS
BR112018013928A2 (en) therapeutic compositions and methods for treating hepatitis b
CY1125113T1 (en) COMPOSITIONS AND METHODS FOR USE IN THE TREATMENT OF HOMOCYSTINURIA
BR112016015997A2 (en) ? PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND 15- HEPE AND METHODS TO TREAT ASTHMA AND PULMONARY DISORDERS WITH THE USE OF THEM?
CL2018003338A1 (en) Physiologically balanced injectable formulations of fosnetupitant.
CO2019002245A2 (en) Fxr agonist combination
BR112018003836A2 (en) btk inhibitor combinations to treat multiple myeloma
CO2017002356A2 (en) Methods for treating depression using nmda modulators

Legal Events

Date Code Title Description
FB Suspension of granting procedure